| Excerpt | Relevance | Reference |
|---|
| "The proteasome has become an important target for cancer therapy with the approval of bortezomib for the treatment of relapsed/refractory multiple myeloma (MM)." | 7.80 | Dyclonine enhances the cytotoxic effect of proteasome inhibitor bortezomib in multiple myeloma cells. ( Ju, D; Xie, Y, 2014) |
| "The proteasome has become an important target for cancer therapy with the approval of bortezomib for the treatment of relapsed/refractory multiple myeloma (MM)." | 3.80 | Dyclonine enhances the cytotoxic effect of proteasome inhibitor bortezomib in multiple myeloma cells. ( Ju, D; Xie, Y, 2014) |